Cargill invests in leading life sciences venture capital fund, Seventure Partners Health for Life Capital II
Investment aims to transform the company’s global microbiome and life sciences R&D for rapid expansion and innovation
Cargill, the global food, agricultural, financial and industrial products company, has announced a significant investment in Seventure Partners’ Health for Life Capital II fund. The investment marks the company’s latest effort to harness its deep expertise and knowledge in nutrition, digestive and immune health with cutting-edge companies to bring next generation ingredient solutions to its customers.
Seventure Partners is a global leader in venture capital, actively funding innovative companies within the two evolving fields of digital technologies and life sciences. Its Health for Life Capital II fund supports the microbiome revolution in the areas of health and nutrition.